alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 76, Number 1 (Monday, January 3, 2011)]
[Notices]
[Pages 107-111]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-33036]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary

[Transmittal Nos. 10-66]


36(b)(1) Arms Sales Notification

AGENCY: Defense Security Cooperation Agency, Department of Defense.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Defense is publishing the unclassified text 
of a section 36(b)(1) arms sales notification. This is published to 
fulfill the requirements of section 155 of Public Law 104-164 dated 21 
July 1996.

FOR FURTHER INFORMATION CONTACT: Ms. B. English, DSCA/DBO/CFM, (703) 
601-3740.

SUPPLEMENTARY INFORMATION: The following is a copy of a letter to the 
Speaker of the House of Representatives, Transmittal 10-66 with 
attached transmittal, policy justification, and Sensitivity of 
Technology.

    Dated: December 28, 2010.
Morgan F. Park,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
BILLING CODE 5001-06-P

[[Page 108]]

[GRAPHIC] [TIFF OMITTED] TN03JA11.008


[[Page 109]]


[GRAPHIC] [TIFF OMITTED] TN03JA11.009


[[Page 110]]


[GRAPHIC] [TIFF OMITTED] TN03JA11.010


[[Page 111]]


[GRAPHIC] [TIFF OMITTED] TN03JA11.011

BILLING CODE 5001-06-C
[FR Doc. 2010-33036 Filed 12-30-10; 8:45 am]
BILLING CODE 5001-06-P
§ 160.185 Dried egg yolks. ( a ) Dried egg yolks, dried yolks is the food prepared by drying egg yolks that conform to § 160.180, with such precautions that the finished food is free of viable *Salmonella* microorganisms. Before drying, the glucose content of the liquid egg yolks may be reduced by one of the optional procedures set forth in paragraph (b) of this section. Either silicon dioxide complying with the provisions of § 172.480 of this chapter or sodium silicoaluminate may be added as an optional anticaking ingredient, but the amount of silicon dioxide used is not more than 1 percent and the amount of sodium silicoaluminate used is less than 2 percent by weight of the finished food. The finished food shall contain not less than 95 percent by weight total egg solids.
( b ) The optional glucose-removing procedures are: ( 1 ) *Enzyme procedure.* A glucose-oxidase-catalase preparation and hydrogen peroxide solution are added to the liquid egg yolks. The quantity used and the time of reaction are sufficient to substantially reduce the glucose content of the liquid egg yolks. The glucose-oxidase-catalase preparation used is one that is generally recognized as safe within the meaning of section 201(s) of the Federal Food, Drug, and Cosmetic Act. The hydrogen peroxide solution used shall comply with the specification of the United States Pharmacopeia, except that it may exceed the concentration specified therein and it does not contain a preservative.
( 2 ) *Yeast procedure.* The pH of the liquid egg yolks is adjusted to the range of 6.0 to 7.0, if necessary, by the addition of dilute, chemically pure hydrochloric acid, and controlled fermentation is maintained by adding food-grade baker's yeast (*Saccharomyces cerevisiae*). The quantity of yeast used and the time of reaction are sufficient to substantially reduce the glucose content of the liquid egg yolks.
( c ) The name of the food for which a definition and standard of identity is prescribed by this section is “Dried egg yolks”, or “Dried yolks”, and if the glucose content was reduced, as provided in paragraph (b) of this section, the name shall be followed immediately by the statement “Glucose removed for stability” or “Stabilized, glucose removed”.
( d ) ( 1 ) When either of the optional anticaking ingredients specified in paragraph (a) of this section is used, the label shall bear the statement “Not more than 1 percent silicon dioxide added as an anticaking agent” or “Less than 2 percent sodium silicoaluminate added as an anticaking agent”, whichever is applicable.
( 2 ) The name of any optional ingredient used, as provided in paragraph (d)(1) of this section, shall be listed on the principal display panel or panels of the label with such prominence and conspicuousness as to render such statement likely to be read and understood by the ordinary individual under customary conditions of purchase.
( e ) *Label declaration.* Each of the ingredients used in the food shall be declared on the label as required by the applicable sections of parts 101 and 130 of this chapter.
[42 FR 14462, Mar. 15, 1977, as amended at 58 FR 2883, Jan. 6, 1993]
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM 10Q 98, FORM
10Q AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JAN-31-1999
<PERIOD-START>                             FEB-02-1998
<PERIOD-END>                               MAY-03-1998
<CASH>                                           7,071
<SECURITIES>                                         0
<RECEIVABLES>                                      719
<ALLOWANCES>                                         0
<INVENTORY>                                    147,512
<CURRENT-ASSETS>                               161,444
<PP&E>                                          19,699
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 194,178
<CURRENT-LIABILITIES>                           54,585
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           285
<OTHER-SE>                                     102,186
<TOTAL-LIABILITY-AND-EQUITY>                   194,178
<SALES>                                         97,796
<TOTAL-REVENUES>                                97,796
<CGS>                                           50,639
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                43,674
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 176
<INCOME-PRETAX>                                  3,307
<INCOME-TAX>                                     1,200
<INCOME-CONTINUING>                              2,107
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     2,107
<EPS-PRIMARY>                                      .10
<EPS-DILUTED>                                      .10
        

</TABLE>
Editorial Note on Part 173
Editorial Note: Nomenclature changes to part 173 appear at 61 FR 14482, Apr. 2, 1996; 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; and 81 FR 49896, July 29, 2016.

§ 173.240 Isopropyl alcohol. Isopropyl alcohol may be present in the following foods under the conditions specified: ( a ) In spice oleoresins as a residue from the extraction of spice, at a level not to exceed 50 parts per million.
( b ) In lemon oil as a residue in production of the oil, at a level not to exceed 6 parts per million.
( c ) In hops extract as a residue from the extraction of hops at a level not to exceed 2.0 percent by weight: *Provided,* That, ( 1 ) The hops extract is added to the wort before or during cooking in the manufacture of beer.
( 2 ) The label of the hops extract specifies the presence of the isopropyl alcohol and provides for the use of the hops extract only as prescribed by paragraph (c)(1) of this section.
§ 16.22 Initiation of regulatory hearing. ( a ) A regulatory hearing is initiated by a notice of opportunity for hearing from FDA. The notice will— ( 1 ) Be sent by mail, telegram, telex, personal delivery, or any other mode of written communication;
( 2 ) Specify the facts and the action that are the subject of the opportunity for a hearing;
( 3 ) State that the notice of opportunity for hearing and the hearing are governed by this part; and
( 4 ) State the time within which a hearing may be requested, and state the name, address, and telephone number of the FDA employee to whom any request for hearing is to be addressed.
( 5 ) Refer to FDA's guideline on electronic media coverage of its administrative proceedings (21 CFR part 10, subpart C).
( b ) A person offered an opportunity for a hearing has the amount of time specified in the notice, which may not be less than 3 working days after receipt of the notice, within which to request a hearing. The request may be filed by mail, telegram, telex, personal delivery, or any other mode of written communication, addressed to the designated FDA employee. If no response is filed within that time, the offer is deemed to have been refused and no hearing will be held.
( c ) If a hearing is requested, the Commissioner will designate a presiding officer, and the hearing will take place at a time and location agreed upon by the party requesting the hearing, the FDA, and the presiding officer or, if agreement cannot be reached, at a reasonable time and location designated by the presiding officer.
( d ) A notice of opportunity for hearing under this section will not operate to delay or stay any administrative action, including enforcement action by the agency unless the Commissioner, as a matter of discretion, determines that delay or a stay is in the public interest.
[44 FR 22367, Apr. 13, 1979, as amended at 49 FR 32173, Aug. 13, 1984]
###### Editorial Note on Part 1315

#### Editorial Note:

Nomenclature changes to part appear at 82 FR 97041, Dec. 30, 2016.

#### § 1315.26 Reduction in individual manufacturing quotas.

The Administrator may at any time reduce an individual manufacturing quota for a chemical that he has previously fixed to prevent the aggregate of the individual manufacturing quotas and import quotas outstanding or to be granted from exceeding the assessment of annual needs that has been established for that chemical pursuant to § 1315.11, as adjusted pursuant to § 1315.13. If a quota assigned to a new manufacturer pursuant to § 1315.23(b), or if a quota assigned to any manufacturer is increased pursuant to § 1315.24(c), or if an import quota issued to an importer pursuant to § 1315.34, causes the total quantity of a chemical to be manufactured and imported during the year to exceed the assessment of annual needs that has been established for that chemical pursuant to § 1315.11, as adjusted pursuant to § 1315.13, the Administrator may proportionately reduce the individual manufacturing quotas and import quotas of all other registrants to keep the assessment of annual needs within the limits originally established, or, alternatively, the Administrator may reduce the individual manufacturing quota of any registrant whose quota is suspended pursuant to § 1315.24(b) or §§ 1301.36, 1309.43, 1309.44, or 1309.45 of this chapter or is abandoned pursuant to § 1315.27.
United States Court of Appeals

for the Fifth Circuit ____________

No. 22-50374

Summary Calendar

____________

United States of America, 

Plaintiff—Appellee,

versus

Nicasio Nevarez-Zamudio, 

Defendant—Appellant.

______________________________

Appeal from the United States District Court 

for the Western District of Texas

USDC No. 4:21-CR-1067-1

______________________________

Before King, Higginson, and Willett, Circuit Judges.

Per Curiam:*

Nicasio Nevarez-Zamudio appeals his conviction and sentence for 

illegal reentry in violation of 8 U.S.C. § 1326(a) and (b)(2), contending that 

the enhancement of his sentence under § 1326(b) is unconstitutional. He has 

filed an unopposed motion for summary disposition and a letter brief 

explaining that he raises this issue only to preserve it for further review,

correctly conceding it to be foreclosed by Almendarez-Torres v. United States, 

_____________________

* This opinion is not designated for publication. See 5th Cir. R. 47.5.

United States Court of Appeals

Fifth Circuit

FILED

February 24, 2023

Lyle W. Cayce

Clerk

Case: 22-50374 Document: 00516655215 Page: 1 Date Filed: 02/24/2023
No. 22-50374

2

523 U.S. 224 (1998). See United States v. Pervis, 937 F.3d 546, 553–54 (5th 

Cir. 2019). 

Because summary disposition is appropriate, see Groendyke Transp., 

Inc. v. Davis, 406 F.2d 1158, 1162 (5th Cir. 1969), Nevarez-Zamudio’s motion 

is GRANTED, and the judgment of the district court is AFFIRMED.

Case: 22-50374 Document: 00516655215 Page: 2 Date Filed: 02/24/2023
xml version="1.0" encoding="UTF-8"?


L\_2008327EN.01004701.xml


| | | | |
| --- | --- | --- | --- |
| 5.12.2008 | EN | Official Journal of the European Union | L 327/47 |

---

Corrigendum to Council Directive 93/92/EEC of 29 October 1993 on the installation of lighting and light-signalling devices on two or three-wheel motor vehicles

(
[Official Journal of the European Communities L 311 of 14 December 1993](http://publications.europa.eu/resource/oj/JOL_1993_311_R_TOC)
)

On page 50, Annex V, point 6.1.10:

for:

| | |
| --- | --- |
| ‘6.1.10. | Circuit-closed telltale: optional.’, |

read:

| | |
| --- | --- |
| ‘6.1.10. | Circuit-closed telltale: compulsory.’ |

On page 52, Annex V, point 6.3.10:

for:

| | |
| --- | --- |
| ‘6.3.10. | Operational telltale: optional.’, |

read:

| | |
| --- | --- |
| ‘6.3.10. | Operational telltale: compulsory.’ |

On page 63, Annex VI, point 6.1.10:

for:

| | |
| --- | --- |
| ‘6.1.10. | Circuit-closed telltale: optional.’, |

read:

| | |
| --- | --- |
| ‘6.1.10. | Circuit-closed telltale: compulsory.’ |

On page 65, Annex VI, point 6.3.10:

for:

| | |
| --- | --- |
| ‘6.3.10. | Operational telltale: optional.’, |

read:

| | |
| --- | --- |
| ‘6.3.10. | Operational telltale: compulsory.’ |

---
IV 

115TH CONGRESS 

1ST SESSION H. RES. 356 

Expressing the sense of the House of Representatives that the Senate should 

give its advice and consent to the ratification of the Convention on 

the Elimination of All Forms of Discrimination Against Women. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 24, 2017 

Mrs. CAROLYN B. MALONEY of New York (for herself and Ms. SCHAKOWSKY) 

submitted the following resolution; which was referred to the Committee 

on Foreign Affairs 

RESOLUTION 

Expressing the sense of the House of Representatives that 

the Senate should give its advice and consent to the 

ratification of the Convention on the Elimination of All 

Forms of Discrimination Against Women. 

1 Resolved, That it is the sense of the House of Rep2 resentatives that— 

3 (1) the full realization of the rights of women 

4 is vital to the development and well-being of people 

5 of all nations; and 

6 (2) the Senate should, therefore, give its advice 

7 and consent to the ratification of the Convention on 


srobinson on DSKBC5CHB2PROD with BILLS
2 

•HRES 356 IH 

1 the Elimination of All Forms of Discrimination 

2 Against Women. 

Æ 


srobinson on DSKBC5CHB2PROD with BILLS
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          MAR-26-2000
<PERIOD-START>                             MAR-29-1999
<PERIOD-END>                               SEP-26-1999
<EXCHANGE-RATE>                                      1
<CASH>                                             798
<SECURITIES>                                         0
<RECEIVABLES>                                    4,555
<ALLOWANCES>                                         0
<INVENTORY>                                      6,044
<CURRENT-ASSETS>                                11,738
<PP&E>                                          91,554
<DEPRECIATION>                                (85,315)
<TOTAL-ASSETS>                                  18,428
<CURRENT-LIABILITIES>                           16,119
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            35
<OTHER-SE>                                      72,681
<TOTAL-LIABILITY-AND-EQUITY>                    18,428
<SALES>                                          7,686
<TOTAL-REVENUES>                                 7,686
<CGS>                                            7,333
<TOTAL-COSTS>                                    7,333
<OTHER-EXPENSES>                                 2,264
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 274
<INCOME-PRETAX>                                (2,185)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (2,185)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (2,185)
<EPS-BASIC>                                    (.65)
<EPS-DILUTED>                                    (.65)


</TABLE>
STATE OF LOUISIANA

COURT OF APPEAL, FIRST CIRCUIT

STATE OF LOUISIANA NO. 2022 KW 0342

VERSUS

PRESTON G. DEMOUCHET, JR. JULY 5, 2022

In Re: Preston G. Demouchet, Jr., applying for supervisory

writs, 16th Judicial District Court, Parish of St. 

Mary, No. 95- 141810. 

BEFORE: McCLENDON, WELCH, AND HESTER, JJ. 

WRIT DENIED. A conviction may not be collaterally attacked

through a motion to correct an illegal sentence. See La. Code

Crim. P. art. 881. 5. It is well established that a pleading is

construed for what it really is and not for what it is labeled. 

Rochon v. Young, 2008- 1349 ( La. App. 1st Cir. 2/ 13/ 09), 6 So. 3d

890, 892, writ denied, 2009- 0745 ( La. 1/ 29/ 10), 25 So. 3d 824. 

If the inmate files a pleading that requests postconviction

relief, the pleading should be treated as such, including the

application of the time limit of article 930. 8. See State v. 

Jarrow, 2004- 0483 ( La. 9/ 24/ 04), 882 So. 2d 1160. 

PMC

JEW

CHH

COURT OF APPEAL, FIRST CIRCUIT

l 0

DEPUTY CLERK OF COURT

FOR THE COURT
Editorial Note on Part 118
Editorial Note: Nomenclature changes to part 118 appear at 81 FR 49896, July 29, 2016.

§ 118.6 Egg testing for Salmonella Enteritidis (SE). ( a ) ( 1 ) If the environmental test for pullets at 14 to 16 weeks of age required by § 118.4(a) is positive, you must divert eggs to treatment (defined in § 118.3) for the life of any flock or conduct egg testing within 2 weeks of the start of egg laying, as specified in paragraphs (b) through (e) of this section.
( 2 ) If you have an SE-positive environmental test at any time during the life of a flock, you must divert eggs to treatment (defined in § 118.3) for the life of the flock in that positive poultry house or conduct egg testing as specified in paragraphs (b) through (e) of this section.
( b ) Eggs must be sampled as described in § 118.7 and tested using methodology as described in § 118.8.
( c ) You must conduct four egg tests, using sampling and methodology in §§ 118.7 and 118.8, on the flock in the positive poultry house at 2-week intervals. If all four tests are negative for SE, you are not required to do further egg testing.
( d ) If any of the four egg tests is positive for SE, you must divert, upon receiving notification of an SE-positive egg test, all eggs from that flock to treatment (defined in § 118.3) until the conditions of paragraph (c) of this section are met.
( e ) If you have a positive egg test in a flock and divert eggs from that flock and later meet the negative test result requirements described in paragraph (c) of this section and return to table egg production, you must conduct one egg test per month on that flock, using sampling and methodology in §§ 118.7 and 118.8, for the life of the flock. ( 1 ) If all the monthly egg tests in paragraph (e) of this section are negative for SE, you may continue to supply eggs to the table market.
( 2 ) If any of the monthly egg tests in paragraph (e) of this section is positive for SE, you must divert eggs from the positive flock to treatment for the life of the flock or until the conditions of paragraph (c) of this section are met.
( f ) If you are diverting eggs, the pallet, case, or other shipping container must be labeled and all documents accompanying the shipment must contain the following statement: “Federal law requires that these eggs must be treated to achieve at least a 5-log destruction of *Salmonella* Enteritidis or processed as egg products in accordance with the Egg Products Inspection Act, 21 CFR 118.6(f).” The statement must be legible and conspicuous.
#### § 200.338 Restrictions on public access to records.

No Federal awarding agency may place restrictions on the non-Federal entity that limit public access to the records of the non-Federal entity pertinent to a Federal award, except for protected personally identifiable information (PII) or when the Federal awarding agency can demonstrate that such records will be kept confidential and would have been exempted from disclosure pursuant to the Freedom of Information Act (5 U.S.C. 552) or controlled unclassified information pursuant to Executive Order 13556 if the records had belonged to the Federal awarding agency. The Freedom of Information Act (5 U.S.C. 552) (FOIA) does not apply to those records that remain under a non-Federal entity's control except as required under § 200.315. Unless required by Federal, state, local, and tribal statute, non-Federal entities are not required to permit public access to their records. The non-Federal entity's records provided to a Federal agency generally will be subject to FOIA and applicable exemptions.
Editorial Note on Part 72
Editorial Note: Nomenclature changes to part 72 appear at 80 FR 74981, Dec. 1, 2015, and at 81 FR 86910, Dec. 2, 2016.

§ 72.128 Criteria for spent fuel, high-level radioactive waste, reactor-related greater than Class C waste, and other radioactive waste storage and handling. ( a ) *Spent fuel, high-level radioactive waste, and reactor-related GTCC waste storage and handling systems.* Spent fuel storage, high-level radioactive waste storage, reactor-related GTCC waste storage and other systems that might contain or handle radioactive materials associated with spent fuel, high-level radioactive waste, or reactor-related GTCC waste, must be designed to ensure adequate safety under normal and accident conditions. These systems must be designed with— ( 1 ) A capability to test and monitor components important to safety,
( 2 ) Suitable shielding for radioactive protection under normal and accident conditions,
( 3 ) Confinement structures and systems,
( 4 ) A heat-removal capability having testability and reliability consistent with its importance to safety, and
( 5 ) means to minimize the quantity of radioactive wastes generated.
( b ) *Waste treatment.* Radioactive waste treatment facilities must be provided. Provisions must be made for the packing of site-generated low-level wastes in a form suitable for storage onsite awaiting transfer to disposal sites.
[53 FR 31658, Aug. 19, 1988, as amended at 66 FR 51843, Oct. 11, 2001]
§ 1.225 Who must register under this subpart? ( a ) You must register your facility under this subpart if you are the owner, operator, or agent in charge of either a domestic or foreign facility, as defined in this subpart, and your facility is engaged in the manufacturing/processing, packing, or holding of food for consumption in the United States, unless your facility qualifies for one of the exemptions in § 1.226.
( b ) If you are an owner, operator, or agent in charge of a domestic facility, you must register your facility whether or not the food from the facility enters interstate commerce.
( c ) If you are the owner, operator, or agent in charge of a facility, you may authorize an individual to register your facility on your behalf.